Markets › United States › NAS › NBTX

Nanobiotix SA

NAS:NBTXHealthcarenasdaq_composite

$24.14+14.52%At closeAt close · Wed 21 Oct · ≈ AED 88.65 · Market cap $1.07B · Next earnings Tue 27 Apr

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	—	—
Operating margin	−1,566.8%	−1,986.4%	−977.8%	−74.0%	951.2%	−36.5%	−36.5%	+0.0 pts
Net margin	−1,444.7%	−1,775.7%	−1,194.3%	−109.6%	947.6%	−80.8%	−80.8%	+0.0 pts
EBITDA margin	−1,499.4%	−1,722.9%	−925.8%	−65.4%	941.1%	−40.7%	—	—
Return on equity	−47.7%	−175.4%	210.9%	2,152.9%	103.7%	28.4%	28.4%	+0.0 pts
Return on assets	−25.1%	−46.2%	−95.4%	−42.3%	−101.1%	−35.4%	−35.4%	+0.0 pts
Return on capital employed	−31.7%	−81.0%	−213.9%	−60.8%	−806.2%	−105.5%	—	—
Debt / equity	0.7×	1.7×	−2.0×	−27.4×	−0.8×	−1.1×	−1.1×	+0.0%
Debt / assets	36.5%	45.2%	89.0%	53.9%	75.5%	140.7%	—	—
Interest coverage	−109.4×	−75.2×	−8.0×	−3.4×	−8.5×	−1.0×	—	—
Current ratio	6.6×	2.5×	1.4×	1.8×	1.0×	1.1×	1.1×	+0.0%
Quick ratio	6.6×	2.5×	1.3×	1.7×	1.0×	1.1×	—	—
Cash ratio	6.3×	2.3×	1.1×	1.5×	0.8×	0.9×	0.9×	+0.0%
Asset turnover	0.0×	0.0×	0.1×	0.4×	−0.1×	0.4×	—	—
Inventory turnover	—	—	0.0×	0.0×	—	—	—	—
Receivables turnover	0.6×	0.7×	1.7×	12.2×	−0.8×	3.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—